Get the Stockscreener App
0.8542
1.57%
0.0132
After Hours:
.85
-0.0042
-0.49%
Carisma Therapeutics Inc Stock (CARM) Forecast
The Carisma Therapeutics Inc (CARM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.8392, representing a +115.31% increase from the current price of $0.8542. The highest analyst price target is $2.3958, and the lowest is $1.2826.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CARM Price Target
Average 3.5084
(+310.72% Upside)
Is Carisma Therapeutics Inc (CARM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.63 | Neutral |
| STOCH(9,6) | 16.66 | Buy |
| STOCHRSI(14) | 41.63 | Neutral |
| MACD(12,26) | -0.0419 | Sell |
| ADX(14) | 19.08 | Neutral |
| William %R | -82.05 | Buy |
| CCI(14) | -26.94 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.8548
Sell
|
0.8697
Sell
|
| MA20 |
0.9376
Sell
|
0.9063
Sell
|
| MA50 |
0.9568
Sell
|
0.9595
Sell
|
| MA100 |
1.0119
Sell
|
1.0819
Sell
|
| MA200 |
1.3878
Sell
|
1.5845
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CARM could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on CARM, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.63 indicates that CARM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 16.66 indicates that CARM is oversold. This indicates that CARM price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 41.63 indicates that CARM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.08 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -26.94 indicates that CARM is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CARM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Carisma Therapeutics Inc financial reports and earnings history, Carisma Therapeutics Inc (CARM) stock could reach $1.0544 by 2030, $15.86 by 2040 and $16.98 by 2050. See the projected annual prices until 2050 of the Carisma Therapeutics Inc stock below:
- Carisma Therapeutics Inc (CARM) is expected to reach an average price of $3.1331 in 2035, with a high prediction of $5.8799 and a low estimate of $4.3631. This indicates an $266.79% rise from the last recorded price of $0.8542.
- Carisma Therapeutics Inc (CARM) stock is projected to chart a bullish course in 2040, with an average price target of $15.27, representing an $1,687% surge from its current level. The forecast ranges from a conservative $16.08 to a sky-high $15.86.
- Our analysts predict Carisma Therapeutics Inc (CARM) to jump 1,230% by 2045, soaring from $11.40 to an average price of $11.36, potentially reaching $11.46. While $11.40 is the low estimate, the potential upside is significant.
- Carisma Therapeutics Inc (CARM) stock is expected to climb by 2050, reaching an average of $17.19, a $1,912% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.98 and $17.22, respectively, highlighting the market's uncertainty.
Carisma Therapeutics Inc Stock (CARM) Year by Year Forecast
Carisma Therapeutics Inc Stock (CARM) Price Forecast for 2025
Carisma Therapeutics Inc Stock (CARM) is expected to reach an average price of $3.5084 in 2025, with a high prediction of $6.9967 and a low estimate of $0.02. This indicates an +310.72% rise from the last recorded price of $0.8542.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.3026 | $1.2826 | $2.3958 | +52.50% |
| February, 2025 | $1.4195 | $1.119 | $1.8781 | +66.18% |
| March, 2025 | $1.9214 | $1.22 | $2.1514 | +124.93% |
| April, 2025 | $1.1437 | $1.0532 | $2.0618 | +33.89% |
| May, 2025 | $1.5055 | $1.0246 | $1.6655 | +76.25% |
| June, 2025 | $1.4474 | $1.3469 | $1.8765 | +69.44% |
| July, 2025 | $0.8097 | $0.7097 | $1.7979 | -5.21% |
| August, 2025 | $0.14 | $0.02 | $1.1002 | -83.61% |
| September, 2025 | $0.6637 | $0.0419 | $0.9537 | -22.30% |
| October, 2025 | $1.8184 | $0.6347 | $4.0574 | +112.87% |
| November, 2025 | $3.4321 | $1.8293 | $4.6921 | +301.79% |
| December, 2025 | $6.8867 | $3.443 | $6.9967 | +706.22% |
Carisma Therapeutics Inc Stock (CARM) Price Forecast for 2026
The predicted value for Carisma Therapeutics Inc (CARM) in 2026 is set at an average of $3.5926. Estimates vary from a peak of $7.1838 to a trough of $0.00128, indicating an +320.58% surge from the present price of $0.8542.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.0504 | $2.3886 | $7.1838 | +257.11% |
| February, 2026 | $4.4841 | $2.5553 | $4.7081 | +424.95% |
| March, 2026 | $1.5879 | $1.4579 | $4.5601 | +85.89% |
| April, 2026 | $0.5025 | $0.3735 | $2.5497 | -41.17% |
| May, 2026 | $0.3262 | $0.1862 | $1.2332 | -61.81% |
| June, 2026 | $0.4399 | $0.0581 | $0.5699 | -48.50% |
| July, 2026 | $0.6146 | $0.3109 | $1.1427 | -28.05% |
| August, 2026 | $0.2483 | $0.0864 | $0.6155 | -70.93% |
| September, 2026 | $0.8029 | $0.0892 | $0.9829 | -6.00% |
| October, 2026 | $0.5666 | $0.4639 | $0.9357 | -33.66% |
| November, 2026 | $0.0204 | $0.0196 | $0.6176 | -97.62% |
| December, 2026 | $1.3072 | $0.00128 | $1.1073 | +53.03% |
Carisma Therapeutics Inc Stock (CARM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Carisma Therapeutics Inc (CARM) is $2.9726, with a high forecast of $5.8927 and a low forecast of $0.0525. This indicates an +248.00% increase from the last price of $0.8542.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1316 | $0.4316 | $1.1958 | -84.59% |
| February, 2027 | $1.0239 | $0.0525 | $2.6511 | +19.87% |
| March, 2027 | $4.5909 | $0.7853 | $5.2009 | +437.45% |
| April, 2027 | $4.5265 | $3.5723 | $5.8927 | +429.91% |
| May, 2027 | $2.562 | $1.1079 | $4.7478 | +199.93% |
| June, 2027 | $1.279 | $1.219 | $3.4902 | +49.73% |
| July, 2027 | $1.2746 | $0.2818 | $1.6604 | +49.21% |
| August, 2027 | $0.3399 | $0.144 | $1.2725 | -60.21% |
| September, 2027 | $0.7829 | $0.3985 | $0.5943 | -8.35% |
| October, 2027 | $0.0527 | $0.5073 | $0.6515 | -93.83% |
| November, 2027 | $0.6418 | $0.1159 | $0.3618 | -24.87% |
| December, 2027 | $0.4748 | $0.7248 | $0.6362 | -44.42% |
Carisma Therapeutics Inc Stock (CARM) Price Forecast for 2028
In 2028, Carisma Therapeutics Inc (CARM) is projected to reach an average price of $2.3069, with a high projection of $4.6015 and a low estimate of $0.0123. This indicates an +170.06% rise from the last price of $0.8542.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.3992 | $0.1306 | $0.1634 | -53.26% |
| February, 2028 | $0.7036 | $0.325 | $0.2236 | -17.63% |
| March, 2028 | $0.6795 | $0.6623 | $0.6967 | -20.46% |
| April, 2028 | $3.0044 | $2.8963 | $2.6544 | +251.72% |
| May, 2028 | $0.4851 | $0.5251 | $1.9426 | -43.20% |
| June, 2028 | $0.9223 | $0.0123 | $0.9423 | +7.97% |
| July, 2028 | $3.4797 | $0.3441 | $4.3097 | +307.37% |
| August, 2028 | $0.469 | $0.149 | $4.6015 | -45.09% |
| September, 2028 | $1.5964 | $0.0566 | $2.0146 | +86.89% |
| October, 2028 | $0.2539 | $0.022 | $2.2723 | -70.28% |
| November, 2028 | $1.7069 | $0.6406 | $1.0069 | +99.82% |
| December, 2028 | $1.9744 | $1.5013 | $1.475 | +131.14% |
Carisma Therapeutics Inc Stock (CARM) Price Forecast for 2029
The 2029 price forecast for Carisma Therapeutics Inc Stock (CARM) is $2.3503 on average, with a high prediction of $4.113 and a low estimate of $0.5875. This represents an +175.14% increase from the previous price of $0.8542.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.6401 | $1.882 | $1.702 | +92.01% |
| February, 2029 | $1.3627 | $1.1246 | $1.0283 | +59.53% |
| March, 2029 | $1.7253 | $1.4209 | $1.4453 | +101.98% |
| April, 2029 | $1.2379 | $1.4079 | $1.5716 | +44.91% |
| May, 2029 | $1.0086 | $1.0241 | $0.976 | +18.07% |
| June, 2029 | $1.6511 | $1.1767 | $1.3011 | +93.30% |
| July, 2029 | $4.33 | $1.5556 | $3.97 | +406.91% |
| August, 2029 | $3.0984 | $3.6783 | $4.113 | +262.72% |
| September, 2029 | $2.3691 | $1.9314 | $2.8461 | +177.35% |
| October, 2029 | $0.8825 | $0.5875 | $1.5268 | +3.31% |
| November, 2029 | $2.9818 | $0.6548 | $3.0918 | +249.07% |
| December, 2029 | $0.7289 | $1.0589 | $3.3103 | -14.67% |
Carisma Therapeutics Inc Stock (CARM) Price Forecast for 2030
Carisma Therapeutics Inc Stock (CARM) is expected to reach an average price of $2.8318 in 2030, with a high forecast of $5.5716 and a low forecast of $0.092. This signifies an +231.52% surge from the last price of $0.8542.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.1727 | $0.092 | $1.0544 | -79.78% |
| February, 2030 | $1.598 | $1.175 | $1.208 | +87.08% |
| March, 2030 | $2.8688 | $1.7957 | $2.5988 | +235.84% |
| April, 2030 | $2.9195 | $2.6041 | $2.4564 | +241.78% |
| May, 2030 | $2.5279 | $2.7779 | $2.7525 | +195.93% |
| June, 2030 | $2.3486 | $2.1332 | $1.9986 | +174.94% |
| July, 2030 | $2.567 | $2.6993 | $2.507 | +200.51% |
| August, 2030 | $1.8777 | $1.9177 | $2.2246 | +119.82% |
| September, 2030 | $1.9884 | $2.0284 | $1.7454 | +132.78% |
| October, 2030 | $2.3668 | $2.3238 | $2.2869 | +177.08% |
| November, 2030 | $5.7144 | $2.3445 | $5.5145 | +568.98% |
| December, 2030 | $4.4133 | $4.7133 | $5.5716 | +416.66% |
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):